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Peritoneal transport characteristics with glucose polymer based dialy-
sate. Dialysate fluids containing glucose polymers as osmotic agent are
different from the conventional solutions, because they are iso-osmotic to
plasma and produce transcapillary ultrafiltration (TCUF) by colloid
osmosis. To investigate the effects on fluid and solute kinetics, a compar-
ison was made between a 7.5% glucose polymer based dialysate (icodex-
trin) and 1.36% and 3.86% glucose based dialysate in 10 stable CAPD
patients. In each patient three standard peritoneal permeability analyses
(SPA) were done with the osmotic agents and concentrations mentioned
above. Dextran 70 was added to the glucose solutions to calculate fluid
kinetics. In the glucose polymer SPAs fluid kinetics were calculated from
the dilution and disappearance of dextrin. The TCUF rate with icodextrin
was closer to that obtained with 3.86% glucose than to 1.36% glucose.
Extrapolation of the fluid profiles revealed sustained ultrafiltration with
icodextrin. TCUF increased linearly in time in the icodextrin tests,
whereas a hyperbola best described the glucose profiles. The effective
lymphatic absorption rate with icodextrin was similar to the glucose based
solutions. Mass transfer area coefficients of low molecular weight solutes
with icodextrin were also similar to the values obtained with glucose, as
was DIP creatinine. A positive correlation was present between the MTAC
creatinine and the TCUF rate with icodextrin (r = 0.66, P = 0.05), which
was absent in the glucose SPAs. This suggests that in patients with a larger
effective peritoneal surface area, more ultrafiltration can be achieved by
glucose polymer solutions. Clearances of /32-microglobulin (132m) were
higher with icodextrin than with 3.86% glucose and 1.36% glucose
dialysate (P < 0.05). No differences were found for the larger serum
proteins albumin, IgG and a2-macroglobulin. Initial D/PNa was higher(0.96) with icodextrin than with the glucose based solutions (0.92), due to
the higher Na concentration of icodextrin, and it remained unchanged
during the dwell. In contrast, D/PNa of 1.36% glucose increased during
the dwell, whereas D/PN decreased with 3.86% glucose until 60 minutes,
followed by a subsequent increase. The ultrafiltration coefficient (UFC) of
the total peritoneal membrane was assessed using 3.86% glucose (0.18
0.04 mI/mm/mm Hg), and the UFC of the small pores was assessed using
icodextrin (0.06 0.008 mI/mm/mm Hg). The difference between these
represented the UFC through the transcellular pores, which averaged
50.5% of the total UFC, but with a very wide range (0 to 85%). An inverse
relation existed between the duration of CAPD treatment and the total
ultrafiltration coefficient (r =
—0.68, P < 0.04), which could be attributed
to a lower UFC of the transcellular pores in long-term patients (r
—0.66,
P < 0.05), but not to the UFC of the small pores (r = —0.48, NS). The
TCUFR06Q ,,,,, through the transcellular pores correlated with the sodium
gradient, corrected for diffusion, in the first hour of the dwell (r = 0.69,
P < 0.04), indicating that both parameters indeed measure transcellular
water transport. it can be concluded that the glucose polymer solution
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induced sustained ultrafiltration and had no effect on peritoneal mem-
brane characteristics. In addition, the results of the present study support
the hypothesis that the glucose polymer solutions exerts its osmotic
pressure across intercellular pores with radii of about 40 A. This leads to
increased clearances of low molecular weight proteins such as f32m that are
transported through these pores without sieving of Na. The latter, as
found during 3.86% glucose dialysate, is probably caused by transcellular
water transport. The transcellular water transport accounted for 50% of
the total ultrafiltration with glucose based dialysis solutions. It was lower
in long-term CAPD patients.
Peritoneal dialysis solutions containing glucose polymers as the
osmotic agent are different from the conventional dialysate fluids,
because they are capable of inducing transcapillary ultrafiltration
even though they are not hypertonic [1, 21. This phenomenon
occurs by colloid osmosis. The process is based upon the principle
that fluid flow across a membrane permeable to small solutes
occurs in the direction of the relative excess of impermeable large
solutes, rather than along the osmolality gradient [3]. The glucose
polymer used in peritoneal dialysis solutions is composed of high
molecular weight fractions, generally obtained by hydrolysis of
corn starch. Mistry, Mallick and Gokal showed that a dialysis
solution containing glucose polymer with a mean molecular
weight of 16,800 yielded more ultrafiltration than 1.36% glucose
dialysate in six hours dwells, despite its lower osmolality (302 vs.
347 mOsm/kg) [11. This suggests colloid osmosis is operating [1],
as opposed to the crystalloid osmosis, which is induced by the
commonly used (hyperosmolar) glucose-based dialysis solutions.
Dialysate osmolality remained stable during the dwell. A 7.5%
solution with a mean molecular weight of 16,800 Da and an
osmolality of 285 mOsm/kg, generically named icodextrin, is
currently available for clinical use. This solution is capable of
producing ultrafiltration similar to 3.86% glucose solutions in 8
and 12 hour dwells without important clinical side effects when
administered once daily [4].
It is unlikely that the transperitoneal fluid transport induced by
glucose occurs only through the small interendothelial pores,
because of the large difference in size between the radius of
glucose (< 3 A) and that of the small pores (40 A). Based on
computer simulations an additional set of ultrasmall pores has
been proposed that allows the passage of water, but not of solutes
[5—81. Glucose is an extremely effective osmotic agent across these
ultrasmall pores, because its reflection coefficient for them is 1.0.
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Table 1. Composition of dialysate solutions used
Methods
Procedure
Calculations in the SPA
(Dx1 — Dx1)ELAR (mi/mm) =
(Dgeom)t
Icodextrin
Glucose
1.36%
Glucose
3.86%
(7.5% glucose
polymer)
Na mmol/ liter 132 132 133
Ca mmollliter 1.75 1.75 1.75
Mg** mmollliter 0.75 0.75 0.25
CL mmol/liter 102 102 97
Lactate mmol/liter 35 35 40
Osmolality 347 486 285
mOsm/kg H20
pH 5.5 5.5 5.8°
using glucose 1.36% dialysate, to avoid the possible effects of the
residual volume before the test and to calculate the residual
volume after the test. Dialysate samples were taken at multiple
time points during the test: at 10, 20, 30, 60, 120, 180 and 240
minutes. Blood samples were drawn at the beginning and at the
end of the test period. A volume marker was used to calculate
fluid kinetics. In the glucose SPAs, dextran 70 (1 g/liter) was
added as a volume marker, whereas in the icodextrin SPAs dextrin
itself was used for that purpose. In the glucose SPAs dextran 1
(Promiten®, NPBI, Emmercompascuum, the Netherlands) was
injected intravenously to prevent a possible anaphylactic reaction
to dextran 70 [11]. For the rinsing procedures in the icodextrin
SPAs a 1.4% glycerol containing dialysate solution (Baxter B.V.,
Utrecht, the Netherlands) was used to avoid the effect of glucose
on the dextrin determinations.
Assays
Total dextran was determined by high performance liquid chro-
matography [12]. Total dextrin was determined as follows: 1.5 ml,
0.75 M NaOH was added to 600 d of the samples. After 15 minutes
of incubation at 100°C, 5 ml of diphenylamine was added, and 25
minutes of incubation followed. After cooling, the absorption was
read at 620 nm. The DAM-TCS Technicon SD4 to 001 method was
used for the measurement of urea. Creatinine was determined with
an enzymatic method (Hitachi H747, Boehringer Mannheim, Ger-
many). Glucose was measured by glucose oxidase-peroxidase
method. Beta-2-microglobulin was determined on an IMx system
using a microparticle enzyme immunoassay (Abbott Diagnostics,
North Chicago, IL, USA). Albumin, IgG and cs2- macroglobulin
were all measured by nephelometsy (BN100, Behring, Marburg,
Germany).
Mean of three observations, other data are given as stated on dialysate
bags
The water channel aquaporin-1 may be the anatomic equivalent of
the ultrasmall transcellular pores, because its presence has been
demonstrated in endothelial cells of peritoneal capillaries and
venules [9]. This implies that glucose-based dialysis solutions
should induce transport of water through both pore systems. In
contrast, icodextrin, containing high molecular weight glucose
polymers, should only exert its effect across the small interendo-
thelial pores because it is not a hypertonic solution.
The aim of the present study was to analyze the effects of
glucose polymer based dialysate on peritoneal membrane charac-
teristics. Comparisons were made between icodextrin and the
conventional glucose based dialysis solutions regarding fluid ki-
netics, the transport of low molecular weight solutes, electrolytes,
and that of serum proteins. In addition, we investigated the
hypothesis that isotonic glucose polymer solutions exert their
osmotic pressure across the small pore system. Combining the
fluid kinetics of glucose with icodextrin enabled us to calculate the
contribution of the transcellular pore system to the total ultrafil-
tration coefficient of the peritoneal membrane.
Three standard peritoneal permeability analyses (SPA) were
performed in 10 stable CAPD patients within a period of one
week (range 5 to 8 days). The three test solutions consisted of
1.36% glucose, 3.86% glucose (Dianeal®, Baxter B.V., Utrecht,
the Netherlands) and a solution containing 7.5% icodextrin
(Icodial®, ML laboratories PLC, Liverpool, UK). The composi-
tion of the fluids is summarized in Table 1. The protocol was
approved by the Committee on Medical Ethics at the Academic
Medical Center, Amsterdam, and written informed consent was
obtained from all patients.
Patients
The patients had a mean age of 48 years (range 23 to 64). The
mean duration of CAPD treatment was 28 months (3 to 92) and
the mean peritonitis incidence was 0.12 (0 to 0.6) episodes per
year. Median residual urine production was 210 ml/day (0 to
2300). None of the patients had had peritonitis during the four
weeks before the experiments were performed, nor in the interval
between the tests.
The SPAs were performed as described previously [10], with
some adaptations for the icodextrin experiments (see below). In
brief, a standardized four-hour dwell was performed with the test
solution. This was preceded and followed by a rinsing procedure
Transport parameters were calculated as described previously
[10]. In brief, the transcapillary ultrafiltration (TCUF) was calcu-
lated from the dilution of the volume marker, taking the theoret-
ical intraperitoneal volume (IPV) at any timepoint, minus the
initial IPV. For icodextrin the best fit for the transcapillary
ultrafiltration data were that of linear regression, whereas for
glucose the Lineweaver-Burk plot was found to fit best [13]. The
latter is based on the relation that is present between the
reciprocal values of TCUF and time [13]. Data on TCUF were
extrapolated to six and nine hour values using the above men-
tioned plots. The initial TCUF, in the first minute of the dwell,
was calculated according to the same plots.
The transcapillary ultrafiltration rate (TCUFR) was obtained
by dividing the TCUF by the dwell time. Calculation of the
dilution of the volume marker after correction for incomplete
recovery yielded the change in IPV (-IPV). The net ultrafiltra-
tion rate was obtained by dividing -1PV by the dwell time. The
convective loss of the volume marker during the dwell was used to
calculate the effective lymphatic absorption rate (ELAR). This
implies that all pathways of lymphatic drainage from the perito-
neal cavity, both subdiaphragmatic and interstitial, are included in
the definition of ELAR. It is calculated according to:
(Eq.I)
In this equation the difference between instilled (i) and recovered
(r) dextran or dextrin mass is divided by the geometric mean of
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the dialysate dextran or dextrin concentration [14]. The dialysatel
plasma ratio of sodium (DIP Nat) was used to analyze the sieving
of sodium, a measure of transcellular water transport [15]. The
concentration gradient of sodium between the dialysate and
plasma was calculated during the first hour of the dwell for the
glucose 1.36% and 3.86% SPAs. The concentration gradient
decreases with glucose 1.36%, due to sodium diffusion from the
circulation. In contrast, it increases with 3.86% glucose because
transcellular water transport causes a decrease of the dialysate
sodium concentration that outweighs the effect of sodium diffu-
sion. Subtraction of the concentration gradient of the 1.36% dwell
from the 3.86% resulted in the net sodium gradient, caused by
transcellular water transport, corrected for diffusion.
Solute transport was expressed as mass transfer area coeffi-
cients (MTAC) of low molecular weight solutes, and clearances of
macromolecules. The MTAC represents the maximal theoretical
diffusive clearance of a solute at t = 0, before transport has
actually started. In the present study the Waniewski model was
used [16]:
Vm V101 _F(p — D10)
MTAC(mllmin)=—ln j1-Fj_1-t t I'
in which a correction factor for convective transport (F) of 0.5 is
applied. V10 represents the intraperitoneal volume, D10 the
dialysate concentration at t = 10 minutes, whereas Vt and D are
these parameters at t = 240 minutes. Vm is the mean intraperi-
toneal volume.
Clearances were used to express the transport of the macro-
molecules /3-2-microglobulin, albumin, IgG and a-2-macroglobu-
lin, according to:
PrDr + PrRVCl (mllmin) = _______(Pr)t
In this equation the total dialysate protein content, both in the
drained test bag (PrOR) and in the residual volume (PrRV),
relative to the plasma protein concentration is calculated. The
restriction coefficient (rc) is the functional characterization of the
___________
intrinsic peritoneal permeability. It is the slope of the power
relation between the clearance of macromolecules and their free
diffusion coefficients in water (Dw) [14, 17, 181:
Cl = aDw't
in which a is a constant.
In addition to SPA parameters, the PET parameter, DIP ratios
of creatinine were also calculated [181.
Calculation of the contribution of the transcellular pores to the
total ultrafiltration coefficient
The ultrafiltration induced by glucose is probably composed of
both convective transport through small interendothelial pores,
and transport through transcellular (water only) pathways. The
contribution of the large pores to osmosis induced ultrafiltration
can be neglected because of their very small number and large
pore size. The colloid osmotic pressure, however, will almost
exclusively be exerted across the small interendothelial pores,
because the ultrasmall pore system is especially involved when an
osmolality gradient is present. This implies that the ultrafiltration
_____________________
coefficient (UFC) of the transcellular pores (tp) can be calculated
from the difference between the total UFC of the peritoneum
(Eq. 2)
(Eq. 3)
(tot), as calculated with glucose 3.86%, and the UFC of the small
pores (sp), calculated with icodextrin:
UFc = UFCO1 — UFCSP (Eq. 5)
The UFC can be calculated from the following equation:
TCUFR = UFC [P — cthH + uz.O] (Eq. 6)
in which TCUFR is the transcapillary ultrafiltration rate, P is the
hydrostatic pressure gradient, fl is the colloid osmotic pressure
gradient, and O is the crystalloid osmotic pressure gradient. a- is
the reflection coefficient that can range from 1.0 (ideal semiper-
meable membrane) to 0 (no osmotic effect). It was assumed that
P, during SPA, has a constant value of 9 mm Hg, as the capillary
pressure is about 17 mm Hg [20] and the intraperitoneal pressure
8 mm Hg while resting [21]. According to Van 't Hoffs law every
mOsmlliter exerts an osmotic pressure of 19.3 mm Hg in the case
of an ideal semipermeable membrane. This implies that the
osmotic pressure generated by an osmotic agent is given by:
[osmolality . ci . 19.3]. The reflection coefficient of albumin is
generally considered to approach 1.0. The reflection coefficient of
icodextrin was calculated using the relation between reflection
coefficients of low molecular weight solutes (urea, urate, glucose,
creatinine), and albumin, and their molecular weights. The mo-
lecular weight of icodextrin (16,800 Da) resulted in a value of
0.767 for the reflection coefficient. The capillary colloid osmotic
pressure (He) was assumed to be determined by the serum
albumin concentration for 75% [22]. To this value 0.4 mOsm was
added because of the Gibbs-Donnan equilibrium [22].
SA1000 4
=
68,000
. + 0.4 . 19.3 (Eq. 7)
= 0.38SA + 7.72 mm Hg
In this equation SA represents serum albumin (glliter), 68,000 is
the molecular weight of albumin, and the factor 1000 converts
osmoles to mosmoles. The osmotic pressure within the peritoneal
cavity (fl), exerted by icodextrin, equals:
DIC 1000
=
16,800
0.767 19.3 (Eq. 8)
= 0.88D1C
in which DIC is the dialysate icodextrin concentration in glliter,
(Eq. 16,800 is the molecular weight of icodextrin, and 0.767 is the
reflection coefficient.
Therefore, the transcapillary ultrafiltration rate through the
small pores (TCUFRS) during the initial phase of the exchange,
before absorption of solutes has taken place, equals:
TCUFRSP = uFc[P — (rl — fl)] (Eq. 9)
=
UFCSP [9 — 0.38SA
— 7.72 + 0.88D1C]
= UFC0[l.28 + 0.88D1C — 0.38SAj
The transcapillaiy ultrafiltration during the first minute of the
dwell was considered to represent the initial transcapillary ultra-
filtration rate.
It implies that the UFC of icodextrin (ID) can be written as:
TCUFR1(ID)
UFCSP 0.88D1C — 0.38SA + (mVmmnlmm Hg)
(Eq.10)
For glucose 3.86%, as similar equation can be given:
zP was kept constant at 9 mm Hg and H, was calculated according
to [Eq. 7]. i.O is the difference between the osmolality of the
dialysis fluid (486 mOsm/liter) and the plasma osmolality of the
patient (Osm). As if glucose averages 0.03 [23], oO = 0.03
(486 — Osm) 19.3 mm Hg. Substitution of these numbers in [Eq.
11] yields:
TCUFRj_imin = UFCO, [9 — 0.38SA — 7.72
+ 0.03(486 — Osm) 19.3]
Rearranging this equation yields:
TGUFRimn(3.86%)
UFC1O =
283 — 0.38SA — 0.58Osm (mVmi Hg)
Statistical analysis
sion was calculated by method of least squares, and for correlation
Spearman rank correlation analysis was used [25].
Results
The medians and ranges of the fluid and solute transport
parameters obtained with the three solutions are given in Table 2.
Fluid transport
The transcapillary ultrafiltration with icodextrin after four
12\ hours was in between that obtained with the glucose solutions, but/ it was closer to the TCUF with glucose 3.86% (P = 0.07) than to
glucose 1.36% (P < 0.01). The effective lymphatic absorption rate
was similar for the three solutions. As a result, NUFR and -IPV
with icodextrin were also between the results obtained with 1.36%
and 3.86% glucose.
(Eq 13) Fluid profiles for 1.36%, 3.86% glucose and icodextrin are givenin Figure 1. Data were extrapolated to six and nine hours
(Methods section). The DIP Na revealed sieving of sodium in
the test with the 3.86% glucose solution, which was absent with
both the 1.36% glucose and with the icodextrin solution (Fig. 2).
Solute transport
The transport of the low molecular weight solutes urea, creat-
mine and urate was similar with the three solutions for both SPA
and PET parameters. However, the clearance of 2-microglobulin
(molecular wt 11,800 Da) was higher with icodextrin (Fig. 3). The
clearances of the larger proteins albumin (molecular wt 68,000
Da), IgG (molecular wt 150,000 Da) and c2-macroglobulin (mo-
lecular wt 820,000 Da) did not show any statistically significant
difference between the three solutions. This resulted in a similar
restriction coefficient.
A correlation was found between TCUFR and MTACcreat (r =
0.66,P < 0.05, Fig. 4) in the icodextrin SPA, which was absent in
the glucose SPAs. The same correlation was found between
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Table 2. Results of solute and fluid transport parameters obtained from standard peritoneal permeability analyses with glucose 1.36%, glucose
3.86% dialysate and icodextrin in 10 stable CAPD patients
Glucose 1.36%
Median Range Median Range
Glucose 3.86% Icodextrin
Median Range
Fluid parameters
TCUFR mI/mm 1.3 0.3-1.8 4.5 0.5—6.4 2.3 1.44.8C
ELAR mI/mm 1.2 0.4—4.6 1.0 0.2—4.4 1.1 0—6.8
NUFR mi/mm —0.1 —2.5—3.3 3.2 —1.5—5.1 1.1 —2—2.3'
-IPV ml —73 —582—185 724 —274—1127 227 437S27
Low molecular weight solutes
MTAC urea mI/mm 17.7 9—27 19.1 12—27 14.1 6—26
MTAC creat tnl/min 12.8 6—21 11.7 6—21 14.3 7—24
MTAC orate mi/mm 9.8 5—16 8.2 4—16 8.9 1—12
DIP creat 0.80 0.57—0.94 0.76 0.57—0.91 0.78 0.58—0.90
Macromolecules
Cl f32-microglobulin p1/mm 955.6 503—1878 1095.3 629—1810 1380.0 826_2034C
Cl albumin p1/mm 90.5 52—234 98.3 62—102 122.0 64—290
Cl IgG p1/mm 47.1 10—30 44.0 28—92 61.5 43—155
Cl a2-macroglobulin p1/mm 16.0 4—45 14.2 9—29 20.8 5—53
Restriction coefficient 2.21 1.7—2.99 2.51 2.15—2.85 2.33 1.93—3.06
Medians and ranges are given. Statistical analysis was performed by test for repeated measurements. Solute and fluid transport is expressed per 1.73
m2. Abbreviations are: Cl, clearance; 1-IPV, change in intraperitoneal volume; DIP creat, dialysate over plasma ratio of creatinine; MTAC; mass transfer
area coefficient; NUFR, net ultrafiltration rate; TCUFR, transcapillary ultrafiltration rate.
P = 0.01 after test for repeated measurements for glucose 1.36% versus icodextrin
P < 0.02 versus both glucose concentrations
P < 0.01 versus both glucose solutions
TCUFRoimin = UFC0[zP — H + oLO] (Eq. 11)
Subtraction of equation (10) from (13) gives the UFC of the
transcellular pore system:
—
TCUFRU 1min(386) TCUFR imjn(ID)UFC —
283 — 0.38SA — 0.58 Osm
—
0.88D1C — 0.38SA + 1.28
(Eq. 14)
Using this equation it was possible to calculate the contribution of
the transcellular pores to the total ultrafiltration coefficient and to
relate this to sieving of sodium and transport parameters.
Results are given as medians and ranges because of asymmetri-
cally distributed data, for most of the parameters. Means SCM
are given for data with a normal distribution. For the comparison
of the results of the three solutions, analysis of variance was
performed by test for repeated measurements [24]. Linear regres-
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Fig. 2. Dialysatelplasma ratios of sodium (DIP sodium) during four hour
dwells with glucose 1.36% (U), glucose 3.86% (0), and 7.5% icodextrin (Y).
During the hypertonic dwell with glucose 3.86% a decrease of D/P sodium
was observed, indicating sieving of sodium through ultrasmall pores,
whereas the glucose polymer solution induced no changes in D/P sodium.
Data are expressed as medians in 10 stahle CAPD patients.
TCUFR and the clearance of p2-microglohulin (r = 0.77, P = 0.02
for icodextrin, but not for both glucose solutions: r —0.04, P =
0.90).
Contribution of transcellular pores to the total ultrafiltration
coefficient
The mean total UFC calculated with 3.86% glucose solutions
was 0.18 0.04 ml/min/mm Hg. The transcellular pores contrib-
uted 50.5 12% to this value. The total UFC showed a significant
negative correlation with the duration of CAPD treatment (r =
Glucose Icodextrin
3.86%
Fig. 3. The clearances of -2 microglobulin (Cl i32m) obtained during four
hour dwells using glucose 1.36%, glucose 3.86% and 7.5% icodextrin in 10
stable C.4PD patients. The Cl 132m with icodextrin was significantly higher
than with both glucose solutions (P = 0.008 vs. 1.36% and P 0.01 vs.
3.86%, test for repeated measurements).
—0.68, P < 0.04), but not with peritonitis incidence (r
—0.12,
NS). This could be attributed to a decrease in the UFCtP (r =
—0.66, P < 0.05), hut not to that of the small pores (r = —0.48,
NS).
The UFC of the small pores showed a positive relation to the
glucose absorption with glucose 3.86% (r = 0.67, P = 0.04), and
to the MTAC of urea (r = 0.63, P = 0.05), but not to the MTACs
of other low molecular weight solutes or to the clearance of
/32-microglobulin.
The concentration gradient of sodium, corrected for diffusion,
was positively related to the TCUFR0_60 ,,,,, through the trans-
cellular pores (r = 0.69, P < 0.04, Fig. 5.). This relation could not
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Fig. 1. The time courses of intraperitoneal volume changes caused by transcapillaiy ultrafiltration (U), lymphatic absorption (•), and resulting in net
ultrafiltration (A) during a four hour dwell using 1.36% glucose (A), 3.86% glucose (B) and 7.5% icodextrin (C) in 10 stable CAPD patients (solid lines).
Data were extrapolated to nine hours values using the Lineweaver-Burk plot for glucose 3.86% and linear regression for icodextrin (dashed lines).
Median values are given.
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be established for the TCUFR0_6() ,,, through the intercellular
pores (r = 0.09, NS). When the sodium gradient was not corrected
for diffusion, this correlation was no longer significant (r = 0.62,
NS).
Discussion
The glucose polymer icodextrin is the only high molecular
weight osmotic agent currently available that can be used safely in
CAPD patients [1. Previous papers have mainly focused on its
effect on net ultrafiltration related to dwell time, and to its
potential side effects [1, 41. In the present study, icodcxtrin was
compared with glucose based dialysis solutions with respect to the
kinetics of fluid transport and the peritoneal transport of various
solutes. The results were used to analyze the mechanism of action
of high molecular weight osmotic agents, and to calculate the
contribution of transcellular water transport during peritoneal
dialysis using glucose based solutions.
Fluid kinetics
The values of parameters for fluid transport with 1.36% glucose
found in the present study were within the normal range of those
found in a recent study we performed in a large group of patients
[10]. The transcapillary ultrafiltration with icodextrin, obtained in
a four hour dwell, was not different from that obtained using
3.86% glucose. The effective lymphatic absorption rate, estimated
from the disappearance of dextran or dextrin, was also similar
between the solutions. The shape of the transcapillary ultrafiltra-
tion versus time curves were, however, markedly different. For the
glucose solutions a hyperbola was found, which is in accordance
with previous observations [8], and can be explained by a decrease
in transcapillary ultrafiltration rate due to absorption of glucose.
In contrast, the transcapillary ultrafiltration with the icodextrin
solution increased almost linearly in time. A strict linear increase
would imply a constant ultrafiltration rate. In theory, this can only
be achieved when there would be no absorption of the glucose
polymer at all. In practice, uptake in the lymphatic system and
some absorption will occur, because the solution is polydisperse
and contains some smaller fractions. Although we measured an
absorption of dextrin of 21 9% during the four-hour dwell
studies, this value did not cause a detectable deviation from
linearity. The absorption of icodextrin is in agreement with
previous studies, which reported an absorption of only 20%
during an overnight dwell [21.An additional possibility to explain
the linear increase of transcapillary ultrafiltration with icodextrin
may be that the flow rate through the small pores has a maximum
and is maximal with icodextrin. When this maximum flow rate
remains to be achieved throughout the dwell, despite some
absorption, differences will not be observed. The sustained
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Fig. 4. A positive correlation was present between the mass transfer area coefficient of creatinine (MTACC,,,,) and the transcapillaty ultrafiltration rate
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TCUFR resulted in an expected higher net ultrafiltration than
with 3.86% glucose from nine hours onwards. This implies that
glucose polymer solutions may be beneficial particularly during
long exchanges, that is, the night dwell in CAPD patients and the
daytime exchange in APD patients.
Solute transport
The comparison of the mass transfer area coefficients of low
molecular weight solutes and DIP creatinine revealed no differ-
ence between the glucose polymer solution and the glucose
solutions. It implies that icodextrin has no effect on the effective
peritoneal surface area. This membrane characteristic is thought
to be mainly determined by the number of perfused capillaries
and can therefore be regarded as an indirect measure of the
number of small pores available for transport. It can be charac-
terized in a functional manner by the mass transfer area coeffi-
cients of low molecular weight solutes, or by the clearance of the
small protein /32-microglobulin (molecular wt 11,800 Da) [26 —29].
The higher clearance of 132-microglobulin with icodextrin seems
to be in conflict with this, but it can be explained by the
mechanism by which the glucose polymers exert their effects
across the small pores (see below).
Sieving of sodium could be detected only in the SPA with 3.86%
glucose. This is in accordance with other studies [31—33], and is
due to the large osmolality gradient causing transcellular water
transport far exceeding diffusion of sodium from the circulation.
Such a gradient was less pronounced with the low glucose
solution, and absent with icodextrin.
The values for the transport of albumin, IgG and a2-macro-
globulin were similar to those found previously [10], and not
different for the three solutions. The transport of macromolecules
is not only dependent on the effective peritoneal surface area, but
also on the intrinsic permeability of the peritoneal membrane [17,
18]. The functional representation of this intrinsic peritoneal
permeability is the restriction coefficient. Changes in the intrinsic
permeability to macromolecules probably reflect changes in the
large pore size [17]. The present study showed no indication that
icodextrin has any effect on this parameter.
Glucose polymers exert their osmotic effect across the small pore
system
The increased clearance of J32-microglobulin on icodextrin is an
indication that the glucose polymers do indeed exert their osmotic
pressure mainly on the small interendothelial pores. Its radius (16
A) allows it to pass through the small pores, both by diffusion and
by convection induced by the colloid osmotic pressure gradient.
The larger macromolecules cannot pass through these pores, and
therefore their clearances were not increased when compared to
glucose based solutions. Two previously reported studies made
the same observation [33, 34]. In the study of Mistry et al, a
1.6-fold increase of the clearance of J32-microglohulin was found
for a solution containing 5% glucose polymer (osmolarity 302
mOsm), compared to 1.36% glucose. In the study of Imholz et a!,
3.86% glucose and icodextrin (7.5% glucose polymer, osmolarity
287 mOsm) were compared. Night dwells with icodextrin resulted
in an increase of the clearance of 2-microglohuIin of 14%. Our
study revealed a 26% increase when compared to 3.86% glucose
and 44% compared to 1.36% glucose.
The relation that was found between the mass transfer area
coefficient of creatinine and transcapillary ultrafiltration rate with
icodextrin is the second item in favor of the hypothesis that the
small pores are the site of action of the glucose polymers. Both
phenomena imply that the larger the peritoneal surface area of a
patient (that is, the more small pores available for transport), the
more water and solutes will indeed be transported. This is in
contrast with the conventional glucose solutions, in which patients
with a large effective peritoneal surface area generally will have
rapid absorption of glucose into the circulation, leading to a
decrease in osmotic gradient, and hence a decrease in ultrafiltra-
tion and convective solute transport. Therefore, second to the
application of glucose polymer solutions during long dwells, it may
prove especially effective in patients with a large effective perito-
neal surface area, termed "high transporters" according to the
PET.
Finally, the absence of sieving of sodium with icodextrin
supports the hypothesis that the isotonic glucose polymer solu-
tions exert their effects over the small pores only, and that the
transcellular pathway is of less importance for this osmotic agent.
Functional characterization and contribution of the transcellular
pore system
Functional characterization of the transcellular pores is possi-
ble by the analysis of the sieving of sodium [15, 30—32]. This most
likely occurs because water is transported through the transcellu-
lar pores, which are impermeable to solutes [5]. With icodextrin,
no important contribution of transcellular water transport was
present, as shown by the absence of sieving of sodium. The initial
DIP of sodium was higher, because of the higher sodium concen-
tration in the icodextrin solution. This absence of sodium sieving
supports our hypothesis that the ultrafiltration coefficient ob-
tained with isotonic glucose polymer solutions can be used as a
representation of the ultrafiltration coefficient of the intercellular
small pores, whereas the ultrafiltration coefficient of 3.86% glu-
cose represents both inter- and transcellular water transport. The
contribution of the large pores is considered to be neglectable for
ultrafiltration, because of their large size and very limited number.
in the present in vivo study the transcellular water transport
contributed an average of 50.5% to the total ultrafiltration
coefficient, but showed a wide range (0 to 85%). In absolute values
the ultrafiltration coefficient of the transcellular pores also had a
much wider range than the ultrafiltration coefficient of the small
pores (0.36 vs. 0.08 mllmin/mm Hg). The contribution of the
transcellular pores to the total ultrafiltration coefficient matches
well with the value calculated by Rippe and Stelin using computer
simulations [5]. The negative correlation of the transcellular
ultrafiltration coefficient with duration of CAPD treatment sug-
gests that the lack of ultrafiltration that some patients experience
after long-term CAPD may be due to impairment of the transcel-
lular pores. It can be speculated that this could be caused by
glycosylation of these proteins by the continuous exposure to
unphysiologically high glucose concentrations. The fact that no
such relation was present with the incidence of peritonitis indi-
cates that peritonitis itself has no direct detrimental effect on the
peritoneal capillaries. The ultrafiltration coefficient of the small
pores was not related to the duration of CAPD treatment. The
strong relation between the TCUFR0_(,() mm through the transcel-
lular pores and the diffusion corrected sodium gradient suggests
that both measure transcellular water transport. The absence of
this relationship with the ultrafiltration coefficient of the intercel-
lular pores further strengthens this concept, because it implies
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that the sieving of sodium is not caused by an increase of water
transport as such, but that it is only dependent on the proportion
that occurs by the transcellular pathway.
It can be concluded that glucose polymer solutions produced
sustained ultrafiltration by colloid osmosis. It had no effect on
peritoneal membrane characteristics, such as effective peritoneal
surface area and intrinsic permeability. The hypothesis that
isotonic glucose polymer solutions exert their osmotic pressure
over the small interendothelial pores has been supported by the
increased clearance of /32-microglobulin, the relation between the
MTAC creatinine and TCUFR, and the absence of sieving of
sodium with icodextrin. The ultrafiltration coefficient of the
transcellular pores accounted for about 50% of the total ultrafil-
tration coefficient. Long-term CAPD was associated with lower
transcellular water transport. For clinical practice these findings
implicate that the use of glucose polymer solutions is especially
indicated in situations where a high exposure to glucose should be
avoided, for exchanges with a long dwell time, and in patients with
ultrafiltration failure, either caused by a large effective peritoneal
surface area ("high transporters") or by impaired transcellular
water transport. The latter two conditions occur especially in
long-term CAPD patients.
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